Company attributes
Venture Capital Firm attributes
Other attributes
Founded in 1993, Capricorn Venture Partners based in Leuven, Belgium. The firm is an independent European manager of venture capital and equity funds, investing in innovative European companies. The firm invests out of the venture capital funds Capricorn Sustainable Chemistry Fund, Capricorn Cleantech Fund, Capricorn Health-tech Fund, and Capricorn ICT Fund.
Through their private venture capital funds, they invest in companies with technological advantages in sustainable chemistry, clean technology, health-technology, digital technologies and artificial intelligence. They are convinced that by investing in new technologies and innovations they believe can make a positive impact on society and contribute to a better and more sustainable world, whilst achieving an acceptable return.
Capricorn Venture Partners' investments include NovoPolymers, Ensartech, Ducatt, Anteryon, FRX Polymers, Neosens, Avantium Technologies, Metallkraft AS and Fluxome.
Their exited investments in Yammer, Nexstim, Avantium Technologies, Mainstay Medical, TiGenix, Sequana Medical, Noona Healthcare, EpiGaN, Ogeda, Mendel Biotechnology and Clear2Pay.